Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter ended 30th June, 2025, published in the Financial Express in English Language and Mumbai Lakshdeep in Marathi Language on 09th August, 2025.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted copies of newspaper advertisements containing its unaudited financial results for the quarter ended 30th June 2025 (Q1 FY2026), as required under SEBI LODR Regulation 47. The results were published in Financial Express (English) and Mumbai Lakshdeep (Marathi) on 9th August 2025, and a QR code linking to the full results was included. On a standalone basis, total income from operations stood at Rs. 1,729.96 lakhs versus Rs. 1,821.57 lakhs in Q1 FY25, while net profit after tax fell sharply to Rs. 70.14 lakhs from Rs. 133.57 lakhs year-on-year. Basic and diluted EPS for the quarter came in at Rs. 0.28 (versus Rs. 0.53 in Q1 FY25). The Audit Committee reviewed and the Board of Directors approved the results at their meeting held on 8th August 2025.
This is a routine procedural compliance filing — the actual results were already filed with the exchanges earlier and the news of standalone profit nearly halving year-on-year is not new here, so no fresh stock reaction is expected from this specific announcement.